<SEC-DOCUMENT>0001104659-16-164571-index.html : 20161230
<SEC-HEADER>0001104659-16-164571.hdr.sgml : 20161230
<ACCEPTANCE-DATETIME>20161230161852
ACCESSION NUMBER:		0001104659-16-164571
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20161230
FILED AS OF DATE:		20161230
DATE AS OF CHANGE:		20161230

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Nabriva Therapeutics AG
		CENTRAL INDEX KEY:			0001641640
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C4
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110
		BUSINESS PHONE:		43 (0)1 740 93-0

	MAIL ADDRESS:	
		STREET 1:		LEBERSTRASSE 20
		CITY:			VIENNA
		STATE:			C4
		ZIP:			1110

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			BURGESS DANIEL D
		CENTRAL INDEX KEY:			0001239650

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37558
		FILM NUMBER:		162077776

	MAIL ADDRESS:	
		STREET 1:		C/O HOLLIS-EDEN PHARMACEUTICALS
		STREET 2:		4435 EASTGATE MALL STE.400
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>a3.xml
<DESCRIPTION>3
<TEXT>
Document 1 - file: a3.html

Document 1 - RAW XML: a3.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>ex-24d1.htm
<DESCRIPTION>EX-24.1
<TEXT>
Document 2 - file: ex-24d1.htm

</DOCUMENT>
</SEC-DOCUMENT>